155 related articles for article (PubMed ID: 24384092)
1. An N-terminal splice variant of human Stat5a that interacts with different transcription factors is the dominant form expressed in invasive ductal carcinoma.
Tan D; Chen KE; Deng C; Tang P; Huang J; Mansour T; Luben RA; Walker AM
Cancer Lett; 2014 Apr; 346(1):148-57. PubMed ID: 24384092
[TBL] [Abstract][Full Text] [Related]
2. Prolactin inhibits BCL6 expression in breast cancer through a Stat5a-dependent mechanism.
Tran TH; Utama FE; Lin J; Yang N; Sjolund AB; Ryder A; Johnson KJ; Neilson LM; Liu C; Brill KL; Rosenberg AL; Witkiewicz AK; Rui H
Cancer Res; 2010 Feb; 70(4):1711-21. PubMed ID: 20124477
[TBL] [Abstract][Full Text] [Related]
3. Role of c-Myb during prolactin-induced signal transducer and activator of transcription 5a signaling in breast cancer cells.
Fang F; Rycyzyn MA; Clevenger CV
Endocrinology; 2009 Apr; 150(4):1597-606. PubMed ID: 19036881
[TBL] [Abstract][Full Text] [Related]
4. Prolactin Drives a Dynamic STAT5A/HDAC6/HMGN2 Cis-Regulatory Landscape Exploitable in ER+ Breast Cancer.
Craig JM; Turner TH; Harrell JC; Clevenger CV
Endocrinology; 2021 May; 162(5):. PubMed ID: 33589921
[TBL] [Abstract][Full Text] [Related]
5. Involvement of STAT5a signaling in morphine-induced up-regulation of the cyclin D1.
Guo L; Li H; Liu H; Li C; Li M; Jiang W; He P; Wang S; McNutt MA; Li G
Biochem Pharmacol; 2009 May; 77(9):1553-60. PubMed ID: 19426693
[TBL] [Abstract][Full Text] [Related]
6. STAT5A is regulated by DNA damage via the tumor suppressor p53.
Mukhopadhyay UK; Cass J; Raptis L; Craig AW; Bourdeau V; Varma S; SenGupta S; Elliott BE; Ferbeyre G
Cytokine; 2016 Jun; 82():70-9. PubMed ID: 26876578
[TBL] [Abstract][Full Text] [Related]
7. Serine residues 726 and 780 have nonredundant roles regulating STAT5a activity in luminal breast cancer.
Woock AE; Grible JM; Olex AL; Harrell JC; Zot P; Idowu M; Clevenger CV
Sci Rep; 2021 Jun; 11(1):13506. PubMed ID: 34188118
[TBL] [Abstract][Full Text] [Related]
8. STAT5 isoforms regulate colorectal cancer cell apoptosis via reduction of mitochondrial membrane potential and generation of reactive oxygen species.
Du W; Wang YC; Hong J; Su WY; Lin YW; Lu R; Xiong H; Fang JY
J Cell Physiol; 2012 Jun; 227(6):2421-9. PubMed ID: 21826656
[TBL] [Abstract][Full Text] [Related]
9. Cells with minimal expression of the JAK/STAT pathway related proteins STAT5a and the prolactin receptor: evidence of an alternate prolactin receptor isoform in breast disease.
Bratthauer GL; Stamatakos MD; Vinh TN
Protein Pept Lett; 2010 Jan; 17(1):104-8. PubMed ID: 20214633
[TBL] [Abstract][Full Text] [Related]
10. miR-221/222 control luminal breast cancer tumor progression by regulating different targets.
Dentelli P; Traversa M; Rosso A; Togliatto G; Olgasi C; Marchiò C; Provero P; Lembo A; Bon G; Annaratone L; Sapino A; Falcioni R; Brizzi MF
Cell Cycle; 2014; 13(11):1811-26. PubMed ID: 24736554
[TBL] [Abstract][Full Text] [Related]
11. Signal transducer and activator of transcription 3 and 5 regulate system Xc- and redox balance in human breast cancer cells.
Linher-Melville K; Haftchenary S; Gunning P; Singh G
Mol Cell Biochem; 2015 Jul; 405(1-2):205-21. PubMed ID: 25896132
[TBL] [Abstract][Full Text] [Related]
12. HDAC6 Deacetylates HMGN2 to Regulate Stat5a Activity and Breast Cancer Growth.
Medler TR; Craig JM; Fiorillo AA; Feeney YB; Harrell JC; Clevenger CV
Mol Cancer Res; 2016 Oct; 14(10):994-1008. PubMed ID: 27358110
[TBL] [Abstract][Full Text] [Related]
13. Notch3 restricts metastasis of breast cancers through regulation of the JAK/STAT5A signaling pathway.
Chen MN; Fang ZX; Wu Z; Bai JW; Li RH; Wen XF; Zhang GJ; Liu J
BMC Cancer; 2023 Dec; 23(1):1257. PubMed ID: 38124049
[TBL] [Abstract][Full Text] [Related]
14. Characterization of ductal and lobular breast carcinomas using novel prolactin receptor isoform specific antibodies.
Ginsburg E; Alexander S; Lieber S; Tarplin S; Jenkins L; Pang L; Heger CD; Goldsmith P; Vonderhaar BK
BMC Cancer; 2010 Dec; 10():678. PubMed ID: 21144038
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of MUC1 splice variants as prognostic markers in patients with ductal carcinoma in situ of the breast.
Schmid BC; Rudas M; Fabjani G; Speiser P; Kaserer K; Leodolter S; Zeillinger R
Oncol Rep; 2003; 10(6):1981-5. PubMed ID: 14534730
[TBL] [Abstract][Full Text] [Related]
16. STAT5 and prolactin participate in a positive autocrine feedback loop that promotes angiogenesis.
Yang X; Meyer K; Friedl A
J Biol Chem; 2013 Jul; 288(29):21184-21196. PubMed ID: 23729680
[TBL] [Abstract][Full Text] [Related]
17. N-terminal truncation of Stat5a/b circumvents PIAS3-mediated transcriptional inhibition of Stat5 in prostate cancer cells.
Dagvadorj A; Tan SH; Liao Z; Xie J; Nurmi M; Alanen K; Rui H; Mirtti T; Nevalainen MT
Int J Biochem Cell Biol; 2010 Dec; 42(12):2037-46. PubMed ID: 20854925
[TBL] [Abstract][Full Text] [Related]
18. STAT5A modulates gastric cancer progression via upregulation of CD44.
Wang S; Fan R; Gao H; Ma X; Wu Y; Xing Y; Wang Y; Jia Y
Genomics; 2023 May; 115(3):110638. PubMed ID: 37196931
[TBL] [Abstract][Full Text] [Related]
19. Loss of Nuclear Localized Parathyroid Hormone-Related Protein in Primary Breast Cancer Predicts Poor Clinical Outcome and Correlates with Suppressed Stat5 Signaling.
Tran TH; Utama FE; Sato T; Peck AR; Langenheim JF; Udhane SS; Sun Y; Liu C; Girondo MA; Kovatich AJ; Hooke JA; Shriver CD; Hu H; Palazzo JP; Bibbo M; Auer PW; Flister MJ; Hyslop T; Mitchell EP; Chervoneva I; Rui H
Clin Cancer Res; 2018 Dec; 24(24):6355-6366. PubMed ID: 30097435
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of STAT5a by Naa10p contributes to decreased breast cancer metastasis.
Zeng Y; Min L; Han Y; Meng L; Liu C; Xie Y; Dong B; Wang L; Jiang B; Xu H; Zhuang Q; Zhao C; Qu L; Shou C
Carcinogenesis; 2014 Oct; 35(10):2244-53. PubMed ID: 24925029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
